Blue Goat CyberBlue Goat CyberSMMedical Device Cybersecurity
    Start here
    Services
    • FDA Premarket Cybersecurity Package
    • Medical Device Penetration Testing
    • Medical Device Threat Modeling
    • FDA Deficiency Response
    • FDA Postmarket Cybersecurity
    • MedTech Compliance Bundle
    See all services
    Products

    Blue Goat products

    • GoatWatch logoGoatWatchSBOM risk management for medical devices
    About
    Resources

    Learn

    • Blog
    • Podcast
    • Webinars
    • Talks & workshops
    • Glossary
    • FAQs

    Playbooks & Tools

    • Guides
    • Playbooks (PDF)
    • Infographics
    • Interactive Tools

    Signals & Proof

    • Goat FeedNew
    • News
    • Medical Device Security News
    • The Goat's Weekly
    • Case Studies
    • Proof / Receipts
    All resources, topic hubs, & collections →
    ⌘K
    Book Strategy SessionHow to prepare →
    Blue Goat Cyber

    Full-service medical device cybersecurity. We protect patients by securing connected medical devices from design through postmarket.

    275+ FDA submissions supported, zero cybersecurity rejections · Mission: 1,000 by 2028

    SDVOSB · Service-Disabled Veteran-Owned Small Business

    We sponsor 10 community projects →

    Services

    • FDA Premarket Cybersecurity Package
    • FDA Deficiency Response
    • Medical Device Threat Modeling
    • Medical Device Penetration Testing
    • FDA Postmarket Cybersecurity
    • All services →
    Services
    • FDA Premarket Cybersecurity Package
    • FDA Deficiency Response
    • Medical Device Threat Modeling
    • Medical Device Penetration Testing
    • FDA Postmarket Cybersecurity
    • All services →

    Company

    • About
    • Core values
    • Manifesto
    • Leadership
    • Why Us
    • Partners
    • Careers
    • Press
    • Press kit
    • Contact
    • Company overviewPDF
    Company
    • About
    • Core values
    • Manifesto
    • Leadership
    • Why Us
    • Partners
    • Careers
    • Press
    • Press kit
    • Contact
    • Company overviewPDF

    Resources

    • Blog
    • Guides
    • Podcast
    • Case studies
    • Monthly Pulse newsletter
    • All resources →
    Resources
    • Blog
    • Guides
    • Podcast
    • Case studies
    • Monthly Pulse newsletter
    • All resources →

    Get in touch

    • info@bluegoatcyber.com
    • 844-939-GOAT
    • Book a strategy session →
    • 1776 N Scottsdale Rd, Unit 727
      Scottsdale, AZ 85257Serving clients worldwide

    Follow

    © 2026 Blue Goat Cyber. All rights reserved.

    • Privacy
    • Terms
    • Cookies
    • Sitemap
    • Accessibility
    • CVD

    MedTech Cybersecurity · Since 2022

    Research/Q3 2026 - Vol. 3

    Operations & Cost

    The Cost of Late Cybersecurity Engagement in MedTech

    Quantifying submission delay, deficiency rate, and remediation cost for teams that engage cybersecurity early vs. late.

    Forthcoming. This page reflects the methodology and structure of an upcoming report. Numeric findings and charts will be published after the analyst extract and legal review are complete. Press contacts can request early access at press@bluegoatcyber.com.
    Christian Espinosa, Founder & CEO at Blue Goat Cyber

    By Christian Espinosa, MBA

    Founder & CEO · Blue Goat Cyber

    Published: September 15, 2026

    Press kit

    Executive summary

    Conventional wisdom holds that cybersecurity engagement after design freeze is more expensive. This report attempts to quantify how much more expensive - and how much faster early-engaged teams reach FDA clearance.

    Engagements are classified into four timing tiers based on when cybersecurity work was initiated relative to design freeze and submission filing. Outcomes (deficiency rate, time-to-clearance, remediation effort) are compared across tiers.

    Pending analyst extract and legal review.

    Methodology

    Sample
    Engagements that reached an FDA outcome between 2022 and 2025.
    Time period
    January 2022 - December 2025
    Inclusion criteria
    • Engagements where the start date of cybersecurity work and the submission filing date are both recorded.
    • Engagements with a final FDA outcome by 31 Dec 2025.
    • Engagements where remediation effort can be estimated from internal time tracking.
    Limitations
    • Cost figures reflect Blue Goat Cyber engagement effort, not the client's total internal cost.
    • Tier assignment uses a simplified four-bucket model and does not capture all engagement-timing nuances.
    • Causation cannot be inferred - early engagers may differ from late engagers in unmeasured ways.
    Anonymization
    • All client and product names removed before analysis; records are keyed by an internal study ID.
    • Device-specific identifiers (510(k) numbers, De Novo numbers, UDIs) stripped from the source dataset.
    • Findings reported only at aggregate level; minimum cell size of 5 to prevent re-identification.
    • Free-text deficiency excerpts paraphrased; no verbatim FDA correspondence is reproduced.

    Key findings

    1. 1. Late-engaged teams receive cybersecurity deficiencies at a higher rate.

      internal extract pending

      Pending extract.

    2. 2. Early-engaged teams clear FDA faster on average.

      internal extract pending

      Pending extract.

    3. 3. Remediation cost grows non-linearly with engagement lateness.

      internal extract pending

      Pending extract.

    Charts

    All charts are free to re-use with attribution to Blue Goat Cyber. Each chart has an embed-friendly URL - see the press kit for the iframe snippet.

    Deficiency rate by engagement-timing tier

    internal extract pending

    Share of submissions receiving a cybersecurity deficiency, by tier.

    Pending data extract - chart will render once the analyst team and legal review approve the underlying numbers.

    Source: Blue Goat Cyber engagement dataset, 2022-2025. · Unit: % of submissions

    Time to clearance by engagement-timing tier

    internal extract pending

    Median days from submission filing to FDA clearance, by tier.

    Pending data extract - chart will render once the analyst team and legal review approve the underlying numbers.

    Source: Blue Goat Cyber engagement dataset, 2022-2025. · Unit: days (median)

    Remediation effort by engagement-timing tier

    internal extract pending

    Median engineering hours required to close cybersecurity deficiencies, by tier.

    Pending data extract - chart will render once the analyst team and legal review approve the underlying numbers.

    Source: Blue Goat Cyber engagement dataset, 2022-2025. · Unit: hours (median)

    Deficiency count vs. weeks-before-filing engagement started

    internal extract pending

    Per-engagement scatter of deficiency count against engagement start time.

    Pending data extract - chart will render once the analyst team and legal review approve the underlying numbers.

    Source: Blue Goat Cyber engagement dataset, 2022-2025. · Unit: deficiencies

    Submission outcome distribution by tier

    internal extract pending

    Share of submissions clearing on first review, after one round of deficiencies, or later.

    Pending data extract - chart will render once the analyst team and legal review approve the underlying numbers.

    Source: Blue Goat Cyber engagement dataset, 2022-2025. · Unit: % of submissions

    Cite this report

    Blue Goat Cyber. (2026). The Cost of Late Cybersecurity Engagement in MedTech. https://bluegoatcyber.com/research/cost-of-late-cybersecurity-engagement-2026

    Sources & references

    Primary sources cited in this article. Links open in a new tab.

    1. 1FDA - Cybersecurity in Medical Devices (Premarket Guidance, 2023)- FDA
    2. 2AAMI TIR57 - Principles for Medical Device Security: Risk Management- AAMI
    3. 3MITRE CWE - Common Weakness Enumeration- MITRE
    4. 4NVD - National Vulnerability Database- NIST
    Ready when you are

    Want a deeper briefing on these findings?

    We host private analyst briefings for journalists, investors, and MedTech regulatory teams.

    Request briefingSee more research